NEW YORK (GenomeWeb) - MetaStat today announced an agreement with the Kaiser Foundation to access tumor samples and clinical data from Kaiser Permanente hospitals.

Under the terms of the agreement, MetaStat will receive de-identified tissue samples, clinical data, and medical histories for up to 500 patients with or without metastatic breast cancer. The firm will test these samples with its MetaSite Breast and MenaCalc Breast diagnostic assays, which aim to predict systemic metastasis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.